PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9399669-6	1997	Addition of SK-BR-3 or BT-474 cell supernatants with high concentrations of soluble HER-2/neu led to a neutralization of anti-HER-2/neu antibody-mediated inhibition of proliferation due to a binding of soluble HER-2/neu by the antibody, which could be demonstrated by immunoprecipitation.	sk-br-3	12-19	erb-b2 receptor tyrosine kinase 2	Homo sapiens	84-93	
9399669-6	1997	Addition of SK-BR-3 or BT-474 cell supernatants with high concentrations of soluble HER-2/neu led to a neutralization of anti-HER-2/neu antibody-mediated inhibition of proliferation due to a binding of soluble HER-2/neu by the antibody, which could be demonstrated by immunoprecipitation.	sk-br-3	12-19	erb-b2 receptor tyrosine kinase 2	Homo sapiens	126-135	
9399669-6	1997	Addition of SK-BR-3 or BT-474 cell supernatants with high concentrations of soluble HER-2/neu led to a neutralization of anti-HER-2/neu antibody-mediated inhibition of proliferation due to a binding of soluble HER-2/neu by the antibody, which could be demonstrated by immunoprecipitation.	sk-br-3	12-19	erb-b2 receptor tyrosine kinase 2	Homo sapiens	84-89	
9399669-6	1997	Addition of SK-BR-3 or BT-474 cell supernatants with high concentrations of soluble HER-2/neu led to a neutralization of anti-HER-2/neu antibody-mediated inhibition of proliferation due to a binding of soluble HER-2/neu by the antibody, which could be demonstrated by immunoprecipitation.	sk-br-3	12-19	erb-b2 receptor tyrosine kinase 2	Homo sapiens	90-93	
7667291-3	1995	This report describes the specific downregulation of ERBB2 protein and mRNA in the breast cancer cell line SK-BR-3 by using antisense DNA phosphorothioates.	sk-br-3	107-114	erb-b2 receptor tyrosine kinase 2	Homo sapiens	53-58	
30833944-8	2019	Importantly, the HER2/neu IgE-sensitized ADMC induced breast cancer cell (SK-BR-3) death through apoptosis.	sk-br-3	74-81	erb-b2 receptor tyrosine kinase 2	Homo sapiens	17-25	
7621247-3	1994	This study investigates the possibility of inhibiting tumor-cell proliferation by blocking c-erbB-2 expression in the human mammary carcinoma cell line SK-Br-3 using chemically modified antisense oligodeoxynucleotides.	sk-br-3	152-159	erb-b2 receptor tyrosine kinase 2	Homo sapiens	91-99	
7682635-3	1993	SK-BR-3, a breast cancer cell line with c-erbB-2 overexpression, can be identified by FCM from a mixed cell suspension using a monoclonal anti-human cytokeratin antibody conjugated with fluorescein isothiocyanate.	sk-br-3	0-7	erb-b2 receptor tyrosine kinase 2	Homo sapiens	40-48	
23469785-7	2013	RESULTS: c-erbB-2 antisense probe was uptake by SK-Br-3 cells in a concentration-dependence manner within a certain range (5, 10, and the Medicine Scientific Research Project of Chongqing Health Bureau (062025)25 mg/L).	sk-br-3	48-55	erb-b2 receptor tyrosine kinase 2	Homo sapiens	9-17	
24339850-8	2012	Then, we used breast cancer cells (SK-BR-3) in blood, and demonstrated selective capture and cancer marker (HER2) detection by RCA.	sk-br-3	35-42	erb-b2 receptor tyrosine kinase 2	Homo sapiens	108-112	
20682652-9	2010	Surprisingly, incubation of the fusion proteins with breast cancer cells that overexpress HER2/neu (SK-BR-3) induced cell death at a dose at which the anti-HER2/neu IgG3 antibody was innocuous.	sk-br-3	100-107	erb-b2 receptor tyrosine kinase 2	Homo sapiens	90-98	
20682652-9	2010	Surprisingly, incubation of the fusion proteins with breast cancer cells that overexpress HER2/neu (SK-BR-3) induced cell death at a dose at which the anti-HER2/neu IgG3 antibody was innocuous.	sk-br-3	100-107	erb-b2 receptor tyrosine kinase 2	Homo sapiens	90-94